DocDollars

Beckman Coulter, Inc.

CA · United States · Reporting entity ID 100000010876

Total reported 2019–2025
$76.7M
#124 of 2,960 reporting companies — 0.1% of all reported industry payments
$41.6M in general payments across 2,234 records, plus $35.1M in research funding across 1,091 records.

How it breaks down

General payments $41,579,978
Research funding $35,115,687

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Beckman Coulter, Inc. reported $76.7M to US doctors and teaching hospitals from 2019 to 2025, ranking #124 of 2,960 reporting companies. 46% of that was research funding and 54% general payments such as consulting, speaking, food and travel. 2,234 general payment records and 1,091 research records were filed.

Common questions about Beckman Coulter, Inc.

How much has Beckman Coulter, Inc. paid US doctors?

Beckman Coulter, Inc. reported $76,695,665 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $41,579,978 in general payments, $35,115,687 in research funding.

How does Beckman Coulter, Inc. rank among drug and device companies?

It ranks #124 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Beckman Coulter, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.